News & Updates

EUS-guided biliary drainage an option for unresectable malignant biliary obstruction

04 Sep 2023 by

Endoscopic ultrasound (EUS)–guided choledocho-doudenostomy (ECDS) can be an option for primary biliary drainage in patients with unresectable malignant distal biliary obstruction (MDBO), and may be preferred when endoscopic retrograde cholangiopancreatography (ERCP) is anticipated to be difficult, according an international randomized controlled trial (RCT) led by researchers from the Chinese University of Hong Kong (CUHK).

EUS-guided biliary drainage an option for unresectable malignant biliary obstruction

04 Sep 2023

The Geneva patient: Another score on the HIV remission board

01 Sep 2023 by

Another HIV patient may be on the way to a cure following stem cell therapy using wild-type (WT) CCR5 donor cells for a rare and aggressive blood cancer.

The Geneva patient: Another score on the HIV remission board

01 Sep 2023

Meta-analysis: TTFields added to SoC improves OS in newly diagnosed GBM in real-world setting

01 Sep 2023 by

Results of a systematic review and meta-analysis suggest that adding tumour-treating fields (TTFields) to standard chemoradiotherapy (CRT) significantly prolongs overall survival (OS) for patients with newly diagnosed glioblastoma multiforme (GBM) treated in the real-world setting.

Meta-analysis: TTFields added to SoC improves OS in newly diagnosed GBM in real-world setting

01 Sep 2023

Original New Drug Application Approvals by US FDA (16-31 August 2023)

01 Sep 2023

New drug applications approved by US FDA as of 16-31 August 2023 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (16-31 August 2023)

01 Sep 2023

Product Highlight - KANJINTI

31 Aug 2023

Trastuzumab Powd for conc for soln for infusion 150 mg

Product Highlight - KANJINTI

31 Aug 2023

Do weak opioids increase risk of GI cancers?

30 Aug 2023 by

Evidence on the association of weak opioids with a higher risk of oesophageal and colorectal cancer is not reliable, but there appears to be a small association with gastric cancer, suggests a study.

Do weak opioids increase risk of GI cancers?

30 Aug 2023

Novel systemic therapies improve survival in prostate cancer patients with visceral metastasis

30 Aug 2023 by

Novel systemic treatments are similarly effective in reducing the risk of progression or death in patients with metastatic hormone-sensitive (mHSPC) and castration-resistant prostate cancer (mCRPC), irrespective of visceral metastasis status, reports a study.

Novel systemic therapies improve survival in prostate cancer patients with visceral metastasis

30 Aug 2023

Prof Katalin Karikó: mRNA technology a versatile tool to transform the future of medicine

30 Aug 2023 by

At an honorary degree conferment ceremony held at the Chinese University of Hong Kong and an interview with MIMS Doctor, Professor Katalin Karikó, a pioneer of mRNA technology, suggested that recent advances in mRNA research can provide a versatile tool for combating various diseases.

Prof Katalin Karikó: mRNA technology a versatile tool to transform the future of medicine

30 Aug 2023

Working out heightens sexual function in men with prostate cancer

29 Aug 2023 by

Prostate cancer treatment upends sexual function in men, but the good news is that supervised resistance and aerobic workout can counter these sexual side effects, according to a study presented at ASCO Breakthrough 2023.

Working out heightens sexual function in men with prostate cancer

29 Aug 2023

Niraparib maintenance prolongs PFS in advanced ovarian cancer

29 Aug 2023 by

Maintenance therapy with niraparib significantly extends progression-free survival (PFS) compared with placebo in patients with newly diagnosed advanced ovarian cancer who responded to treatment with first-line platinum-based chemotherapy, according to the PRIME* trial.

Niraparib maintenance prolongs PFS in advanced ovarian cancer

29 Aug 2023

News & Updates

Filter by Specialty:

Specialty:

EUS-guided biliary drainage an option for unresectable malignant biliary obstruction

EUS-guided biliary drainage an option for unresectable malignant biliary obstruction

The Geneva patient: Another score on the HIV remission board

The Geneva patient: Another score on the HIV remission board

Meta-analysis: TTFields added to SoC improves OS in newly diagnosed GBM in real-world setting

Meta-analysis: TTFields added to SoC improves OS in newly diagnosed GBM in real-world setting

Original New Drug Application Approvals by US FDA (16-31 August 2023)

Original New Drug Application Approvals by US FDA (16-31 August 2023)

Product Highlight - KANJINTI

Product Highlight - KANJINTI

Do weak opioids increase risk of GI cancers?

Do weak opioids increase risk of GI cancers?

Novel systemic therapies improve survival in prostate cancer patients with visceral metastasis

Novel systemic therapies improve survival in prostate cancer patients with visceral metastasis

Prof Katalin Karikó: mRNA technology a versatile tool to transform the future of medicine

Prof Katalin Karikó: mRNA technology a versatile tool to transform the future of medicine

Working out heightens sexual function in men with prostate cancer

Working out heightens sexual function in men with prostate cancer

Niraparib maintenance prolongs PFS in advanced ovarian cancer

Niraparib maintenance prolongs PFS in advanced ovarian cancer